[Congressional Bills 107th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1144 Introduced in House (IH)]
107th CONGRESS
1st Session
H. R. 1144
To provide for an increase in the Federal investment in research on
cancer, Alzheimer's disease, and asthma by $2,000,000,000 for fiscal
year 2002, and to express the sense of the House of Representatives
that the Federal investment in such research should further be
increased for each of the fiscal years 2003 through 2006.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
March 21, 2001
Mr. Engel introduced the following bill; which was referred to the
Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To provide for an increase in the Federal investment in research on
cancer, Alzheimer's disease, and asthma by $2,000,000,000 for fiscal
year 2002, and to express the sense of the House of Representatives
that the Federal investment in such research should further be
increased for each of the fiscal years 2003 through 2006.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Disease Research Revitalization Act
of 2001''.
SEC. 2. FINDINGS.
The Congress finds as follows:
(1) Past investments in cancer and Alzheimer's disease
research have resulted in better health, an improved quality of
life for all Americans, and a reduction in national health care
expenditures.
(2) The Nation's commitment to cancer and Alzheimer's
disease research has expanded the base of scientific knowledge
about health and disease and revolutionized the practice of
medicine.
(3) The Federal Government is the single largest
contributor to medical research conducted in the United States.
(4) Research continues to play a vital role in the growth
of this Nation's biotechnology and pharmaceutical industries.
(5) The origin of many of the new drugs and procedures
currently in use is based on cancer and Alzheimer's disease
research supported by the National Institutes of Health.
(6) Unless we make a new commitment to cancer and
Alzheimer's disease research, one out of two American alive
today will fall victim to one or both of these diseases.
(7) Neurodegenerative diseases of the elderly, such as
Alzheimer's disease, threaten to destroy the lives of millions
of Americans, overwhelm the Nation's health care system, and
bankrupt the Medicare and Medicaid programs.
(8) Cancer is the second leading cause of death, and
552,000,000 Americans will die from the disease this year. This
year, doctors will tell 1,200,000 Americans they have cancer.
(9) Women have traditionally been underrepresented in
medical research protocols, yet are severely affected by
diseases including breast cancer, which will kill over 43,900
women this year. Ovarian cancer will claim another 14,500
lives.
(10) Approximately one out of every six American men will
develop prostate cancer, and over 49,200 men will die from the
disease each year.
(11) Four million Americans currently suffer from
Alzheimer's disease and another 360,000 will be diagnosed with
the disease this year. Alzheimer's disease is the fourth
leading cause of death in adults.
(12) As the population of this Nation grows older, the
number of Americans diagnosed with Alzheimer's disease could
double.
(13) The mapping and sequencing of the entire human genome
will lead to a new era of molecular medicine that will provide
unprecedented opportunities for the prevention, diagnosis,
treatment, and cure of diseases that currently plague society.
(14) The fundamental way science is conducted is changing
at a revolutionary pace, demanding a far greater investment in
emerging new technologies and research training programs, and
in developing new skills among scientific investigators.
(15) Research about prevention and early diagnosis of
cancer and Alzheimer's disease may result in significantly
reducing the incidence of these two diseases.
(16) Most Americans show overwhelming support for an
increased Federal investment in cancer and Alzheimer's disease
research and researchers now have unprecedented opportunities
to conquer these two diseases.
(17) About 14,600,000 Americans are suffering with asthma,
resulting in over $6,000,000,000 in health care costs each
year.
(18) Almost 5,000,000 children are afflicted with asthma
today and the number continues to rise, making it the leading
child disease in America.
SEC. 3. ADDITIONAL AUTHORIZATION OF APPROPRIATIONS FOR FISCAL YEAR 2002
REGARDING FEDERAL INVESTMENT IN CANCER, ALZHEIMER'S
DISEASE, AND ASTHMA RESEARCH.
(a) In General.--In addition to other authorizations of
appropriations that are available for fiscal year 2002 for the purpose
of conducting and supporting research on cancer, Alzheimer's disease,
and asthma through the National Institutes of Health, there is
authorized to be appropriated $2,000,000,000 for such purpose for
fiscal year 2002.
(b) Sense of House Regarding Budget Resolution.--It is the sense of
the House of Representatives that the concurrent resolution on the
budget for fiscal year 2002 should appropriately reflect the
authorization of appropriations established in subsection (a).
SEC. 4. SENSE OF HOUSE OF REPRESENTATIVES REGARDING AUTHORIZATIONS OF
APPROPRIATIONS FOR FISCAL YEAR 2003 THROUGH 2006.
It is the sense of the House of Representatives that funding for
the National Institutes of Health to conduct and support research on
cancer, Alzheimer's disease, and asthma should be increased--
(1) for fiscal year 2003, by $2,000,000,000 over the amount
appropriated for fiscal year 2002; and
(2) for each of the fiscal years 2004 through 2006, by
$1,000,000,000 over the amount appropriated for the preceding
fiscal year.
<all>